More than half of men over 50 suffer from urinary problems and reduced quality of life due to benign prostatic hyperplasia (BPH) or prostate enlargement that blocks the urine flow. This translates to 40 million patients in the US and 500 million patients worldwide having to urinate frequently or urgently, even waking up in the middle of the night.
Medications provide only temporary relief and need to be taken daily for years. Medications can also cause side effects such as retrograde ejaculation or dizziness, so about one out of four patients on medications stop taking them. Invasive surgeries that remove parts of the prostate can have severe complications related to sexual function and bleeding, while recent minimally invasive surgeries can be expensive for the patients and difficult for the surgeons.
Our minimally invasive surgical device will provide a rapid and permanent relief of BPH symptoms without complications. Our goal is to encourage patients to move from medications to our procedure sooner in the progression of their disease. Our short procedure will allow fast recovery for patients and high patient throughput for the hospitals. We have made our minimum viable product and test samples for biocompatibility testing.